Molecular Basis for the Selectivity of DHA and EPA in Sudlow’s Drug Binding Sites in Human Serum Albumin with the Combined Use of NMR and Docking Calculations

Medium- and long-chain saturated and unsaturated free fatty acids (FFAs) are known to bind to human serum albumin (HSA), the main plasma carrier protein. Atomic-level structural data regarding the binding mode in Sudlow’s sites I (FA7) and II (FA4, FA3) of the polyunsaturated ω-3 fatty acids docosah...

Full description

Bibliographic Details
Main Authors: Eleni Alexandri, Themistoklis Venianakis, Alexandra Primikyri, Georgios Papamokos, Ioannis P. Gerothanassis
Format: Article
Language:English
Published: MDPI AG 2023-04-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/28/9/3724
_version_ 1827742875544190976
author Eleni Alexandri
Themistoklis Venianakis
Alexandra Primikyri
Georgios Papamokos
Ioannis P. Gerothanassis
author_facet Eleni Alexandri
Themistoklis Venianakis
Alexandra Primikyri
Georgios Papamokos
Ioannis P. Gerothanassis
author_sort Eleni Alexandri
collection DOAJ
description Medium- and long-chain saturated and unsaturated free fatty acids (FFAs) are known to bind to human serum albumin (HSA), the main plasma carrier protein. Atomic-level structural data regarding the binding mode in Sudlow’s sites I (FA7) and II (FA4, FA3) of the polyunsaturated ω-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), however, are largely unknown. Herein, we report the combined use of saturation transfer difference (STD) and Interligand NOEs for Pharmacophore Mapping (INPHARMA) NMR techniques and molecular docking calculations to investigate the binding mode of DHA and EPA in Sudlow’s sites Ι and ΙΙ of HSA. The docking calculations and the significant number of interligand NOEs between DHA and EPA and the drugs warfarin and ibuprofen, which are stereotypical ligands for Sudlow’s sites I and II, respectively, were interpreted in terms of competitive binding modes and the presence of two orientations of DHA and EPA at the binding sites FA7 and FA4. The exceptional flexibility of the long-chain DHA and EPA and the formation of strongly folded structural motives are the key properties of HSA–PUFA complexes.
first_indexed 2024-03-11T04:12:30Z
format Article
id doaj.art-cae3848439c940b2b2a1fdaddfa627ce
institution Directory Open Access Journal
issn 1420-3049
language English
last_indexed 2024-03-11T04:12:30Z
publishDate 2023-04-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj.art-cae3848439c940b2b2a1fdaddfa627ce2023-11-17T23:22:36ZengMDPI AGMolecules1420-30492023-04-01289372410.3390/molecules28093724Molecular Basis for the Selectivity of DHA and EPA in Sudlow’s Drug Binding Sites in Human Serum Albumin with the Combined Use of NMR and Docking CalculationsEleni Alexandri0Themistoklis Venianakis1Alexandra Primikyri2Georgios Papamokos3Ioannis P. Gerothanassis4Section of Organic Chemistry and Biochemistry, Department of Chemistry, University of Ioannina, GR-45110 Ioannina, GreeceSection of Organic Chemistry and Biochemistry, Department of Chemistry, University of Ioannina, GR-45110 Ioannina, GreeceSection of Organic Chemistry and Biochemistry, Department of Chemistry, University of Ioannina, GR-45110 Ioannina, GreeceSection of Organic Chemistry and Biochemistry, Department of Chemistry, University of Ioannina, GR-45110 Ioannina, GreeceSection of Organic Chemistry and Biochemistry, Department of Chemistry, University of Ioannina, GR-45110 Ioannina, GreeceMedium- and long-chain saturated and unsaturated free fatty acids (FFAs) are known to bind to human serum albumin (HSA), the main plasma carrier protein. Atomic-level structural data regarding the binding mode in Sudlow’s sites I (FA7) and II (FA4, FA3) of the polyunsaturated ω-3 fatty acids docosahexaenoic acid (DHA) and eicosapentaenoic acid (EPA), however, are largely unknown. Herein, we report the combined use of saturation transfer difference (STD) and Interligand NOEs for Pharmacophore Mapping (INPHARMA) NMR techniques and molecular docking calculations to investigate the binding mode of DHA and EPA in Sudlow’s sites Ι and ΙΙ of HSA. The docking calculations and the significant number of interligand NOEs between DHA and EPA and the drugs warfarin and ibuprofen, which are stereotypical ligands for Sudlow’s sites I and II, respectively, were interpreted in terms of competitive binding modes and the presence of two orientations of DHA and EPA at the binding sites FA7 and FA4. The exceptional flexibility of the long-chain DHA and EPA and the formation of strongly folded structural motives are the key properties of HSA–PUFA complexes.https://www.mdpi.com/1420-3049/28/9/3724HSADHAEPASTD NMRINPHARMA NMRdocking calculations
spellingShingle Eleni Alexandri
Themistoklis Venianakis
Alexandra Primikyri
Georgios Papamokos
Ioannis P. Gerothanassis
Molecular Basis for the Selectivity of DHA and EPA in Sudlow’s Drug Binding Sites in Human Serum Albumin with the Combined Use of NMR and Docking Calculations
Molecules
HSA
DHA
EPA
STD NMR
INPHARMA NMR
docking calculations
title Molecular Basis for the Selectivity of DHA and EPA in Sudlow’s Drug Binding Sites in Human Serum Albumin with the Combined Use of NMR and Docking Calculations
title_full Molecular Basis for the Selectivity of DHA and EPA in Sudlow’s Drug Binding Sites in Human Serum Albumin with the Combined Use of NMR and Docking Calculations
title_fullStr Molecular Basis for the Selectivity of DHA and EPA in Sudlow’s Drug Binding Sites in Human Serum Albumin with the Combined Use of NMR and Docking Calculations
title_full_unstemmed Molecular Basis for the Selectivity of DHA and EPA in Sudlow’s Drug Binding Sites in Human Serum Albumin with the Combined Use of NMR and Docking Calculations
title_short Molecular Basis for the Selectivity of DHA and EPA in Sudlow’s Drug Binding Sites in Human Serum Albumin with the Combined Use of NMR and Docking Calculations
title_sort molecular basis for the selectivity of dha and epa in sudlow s drug binding sites in human serum albumin with the combined use of nmr and docking calculations
topic HSA
DHA
EPA
STD NMR
INPHARMA NMR
docking calculations
url https://www.mdpi.com/1420-3049/28/9/3724
work_keys_str_mv AT elenialexandri molecularbasisfortheselectivityofdhaandepainsudlowsdrugbindingsitesinhumanserumalbuminwiththecombineduseofnmranddockingcalculations
AT themistoklisvenianakis molecularbasisfortheselectivityofdhaandepainsudlowsdrugbindingsitesinhumanserumalbuminwiththecombineduseofnmranddockingcalculations
AT alexandraprimikyri molecularbasisfortheselectivityofdhaandepainsudlowsdrugbindingsitesinhumanserumalbuminwiththecombineduseofnmranddockingcalculations
AT georgiospapamokos molecularbasisfortheselectivityofdhaandepainsudlowsdrugbindingsitesinhumanserumalbuminwiththecombineduseofnmranddockingcalculations
AT ioannispgerothanassis molecularbasisfortheselectivityofdhaandepainsudlowsdrugbindingsitesinhumanserumalbuminwiththecombineduseofnmranddockingcalculations